Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
3
×
startups
3
×
biotech
illumina
new york blog main
new york top stories
san diego blog main
san diego top stories
spinal muscular atrophy
vc
abiraterone
ac immune
acorda therapeutics
adeno-associated virus
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexandria venture investments
alexion pharmaceuticals
altitude life science ventures
alzheimer's disease
american society of gene and cell therapy
apalutamide
arch venture partners
atypical hemolytic uremic syndrome
bill cassidy
biogen
boston
boulder/denver blog main
boulder/denver top stories
boxer capital
caelum biosciences
What
gene
3
×
bio
alzheimer’s
companies
create
crispr
crude
cutting
despite
diagnostic
different
diseases
drug
edge
editing
effects
encoded
fail
fix
heats
help
high
human
illumina’s
increases
lasting
latest
launches
limited
limits
long
medicine
medicines
nabs
pharmaceutical
plan
prescription
price
prices
progress
Language
Current search:
gene
×
" san francisco top stories "
×
startups
×
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More